Dry Eye Syndrome Market 2025: Industry Developments, Future Growth, Share & Industry Insights | OASIS Medical Inc, Prestige Consumer Healthcare Inc, OCuSOFT, Otsuka Pharmaceutical

Dry Eye Syndrome Market reached US$ 6.12 billion in 2023 and is expected to reach US$ 11.35 billion by 2031, growing at a CAGR of 8.1% during the forecast period 2024-2031

DataM Intelligence has published a new research report on "Dry Eye Syndrome Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/dry-eye-syndrome-market?sg

Key Players: AbbVi, Viatris Inc, Sun Pharmaceutical Industries, Inc, Bausch + Lomb, Alcon Inc, Santen Pharmaceutical Co., Ltd, OASIS Medical, Inc, Prestige Consumer Healthcare Inc, OCuSOFT, Otsuka Pharmaceutical Co., Ltd.

USA - Industry Latest News 2025:

✅ May 28, 2025 - Alcon announced FDA approval of TRYPTYR (acoltremon) ophthalmic solution 0.003% for signs & symptoms of dry eye disease.

✅ May 30, 2025 - US outlets reported the FDA approval (coverage summarizing the new treatment's role stimulating tear production).

✅ Apr 03, 2025 - FDA issued a complete response / declined approval for Aldeyra's reproxalap (dry-eye candidate), asking for more evidence a major setback for that program.

✅ (mid-2025 reporting: Jul 25, 2025) - Clinical update: Stuart Therapeutics reported Phase-3 data for ST-100 (a collagen-mimetic topical) showing tolerability and promising signals in dry eye - an investigational non-traditional approach to ocular surface repair.

Japan - Industry Latest News 2025:

✅ (throughout 2025) - Santen remained active in ophthalmology across Asia; company notices in 2025 reference resumption/availability updates for products including dry-eye related shipments in regional markets (DIQUAS LX mentions in 2025 news).

✅ Sep 30, 2025 - (regional launch item reported) Rohto rolled out a new dry-eye product ("Rohto Dry Aid") in selected APAC markets - notable because Rohto is a major OTC/consumer eye-care brand out of Japan.

South Korea - Industry Latest News 2025:

✅ Oct 16, 2025 - (company announcement) Santen Korea posted an announcement regarding the resumption of shipments for the dry-eye product DIQUAS LX Ophthalmic Solution 3%, and Santen filed local partner/exclusive arrangements in Korea during 2025. (This affects product availability in Korea).

Europe - Industry Latest News 2025:

✅ Apr 09, 2025 - Nordic Pharma announced CE-mark approval for Lacrifill® canalicular gel, paving the way for European launches of the hyaluronic-acid-based tear-retention injectable.

✅ Jun 02, 2025 - (regulatory note) Santen received EC/CHMP positive opinions and activity in mid-2025 for ophthalmic products (company-level European activity strongly visible through 2025).

Growth Forecast Projected:
The Global Dry Eye Syndrome Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Dry Eye Syndrome Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=dry-eye-syndrome-market?sg

Key Segments:

By Type (Aqueous Deficient Dry Eye, Evaporative Dry Eye, Mixed)

By Treatment Type (Artificial Tears, Anti-Inflammatory Drugs , Cyclosporine , Lifitegrast , Corticosteroids , Others)

By Dosage Form (Gels, Eye Solutions, Ointments, Nasal Spray, Oral Formulations)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Dry Eye Syndrome producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Dry Eye Syndrome revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/dry-eye-syndrome-market?sg

FAQ's

Q1: What is the current size of the Dry Eye Syndrome Market?

A: The Dry Eye Syndrome Market stood at US$ 6.12 billion in 2023 and is set to experience remarkable growth, reaching US$ 11.35 billion by 2031

Q2: How fast is the Dry Eye Syndrome Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 8.1% from 2024-2031

Q3: Which regions are dominating the Dry Eye Syndrome Market and which are fastest-growing?

A: North America is expected to hold a significant position in the dry eye syndrome market share.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/dry-eye-syndrome-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.